Global cell and tissue technology market is estimated to rise with the CAGR of 6.56% during the forecast period 2016-2023. Cell and tissue culture is the process of extracting cells and tissues from plants and animals and growing them in controlled artificial environment by providing nutrition, humidity condition and favorable temperature. This process of removing and separating cells or tissues is called cultivation and it is done by various methods such as mechanical or enzymatic procedure and even deriving them from an artificially established cell line. The factors driving the global cell and tissue technology market are as follows:

• Rising cancer case
• Increasing cases of chronic and inferior diseases
• Enhancing health industry
• Advanced technology products
• Increasing government and private funding for cell based research

The key factor contributing to the growth of global cell and tissue technology market is increasing cancer cases day by day. Due to increasing number of chronic cases such as asthma and multiple sclerosis and diseases such as cancer and diabetes, the demand of cell and tissue technology has increased globally. World Health Organization stated that cancer cases are expected to reach up to 15 million by 2020. Lung cancer is the most common type of cancer among men globally. According to WHO, it has been recorded that in 2014 more than 1.3 million new lung cancer cases were found among the males, globally. Breast cancer is one of the most common types of cancer among women in both developed and developing countries. In 2014 more than 1.7 million new breast cancer cases were diagnosed among females globally, 870000 cancer cases of stomach, 560000 cancer cases of cervical, 410000 cancer cases of head and neck and many more. According to World Health Organization, in 2015, it was seen that in U.S., more than 1658370 new cancer cases were diagnosed, among which more than 848200 were male cancer cases and 810170 female cancer cases. It has also been recorded that more than 589430 deaths are caused due to cancer, among which more than 312150 are male and 277280 females. There key opportunities of the cell and tissue technology market   includes Increasing demand in emerging countries due to rising cancer cases in emerging nations For example, in India, in 2015, more than 666,563 deaths were caused due to cancer among which 305,000 are females and 361,474 males. Due to increasing chronic cases and deaths due to cancer, the demand for medical checkups fueled the market of cell and tissue technology. Apart from this the Increasing cost of cell technologies system, Complex and time consuming guidelines which increase the approval process,  Cognitive property right issues restrict innovations in assay kits and strict government regulation for medical sector. Along with this the major challenges associated with the cell and tissue technology market is Dearth of skilled and knowledgeable professionals and market cannibalization of existing technologies by new and upcoming technologies.

 

Source: OBRC Analysis

The global cell and tissue technology market segments includes consumables, instruments, process and end-users. Consumables is further sub segmented into:

• Reagents
• Assay kits
• Micro plates
• Others

Instruments type is further segmented into:

• Microscope
• Flow cytometry
• Spectrophotometers
• QPCR
• Cell counters
• High-content screening (HCS) systems
• Cell microarrays

Process is further segmented into:

• Single-cell technologies
• Target identification and validation
• Cell structure study
• Cell interaction
• Cell counting and quality control 
• Cell proliferation
• Cell signaling pathways/signal transduction

End-user is further segmented into:

• Hospitals and academic & research institutes
• Laboratories
• Cell culture collection repositories
• Pharmaceutical & biotechnology companies
• Other end-users

The revenue for the above end-user segments are specific to global cell and tissue technology market. However, the total revenue of these end-users in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up process and type segment. Geographically, the global cell and tissue technology market is segmented into:

• North America (U.S. & Canada)
• Asia Pacific (China, India, Japan, RoAPAC)
• Europe (UK, France, Germany, RoE)
• Rest of World

North America is anticipated to be the largest market share holder in terms of revenue and the fastest growing region during forecast period of 2016-2023, followed by Europe and Asia Pacific. It is due to the up gradation in the cell culture tools and increasing demand of animal component free media. The APAC region tends to be a developing market with a numerous opportunity of growth in China, Japan, Australia, and India, and these are likely to have huge investments from new investors in the cell and tissue technology market. Drug discovery services outsourcing and government funding for novel screening technologies has resulted in the growth of Asian Pacific region.

The cell and tissue technology is segmented on the basis of consumables, instruments, process and end users. The consumable is further sub segmented as reagents, assay kits, micro plates and other consumables. The instruments are further segmented into microscopes, flow cytometry, spectrophotometers, QPCR, cell counters, high-content screening (HCS) systems and cell microarrays. The flow cytometer is further sub segmented as flow cytometer instruments and flow cytometer software. On the basis of process, the market is further segmented as cell signaling pathways/signal transduction, cell proliferation, cell counting and quality control, cell structure stud, cell interactiony, target identification and validation and single-cell technology. On the basis of end users, the market is further segmented as hospitals and academic & research institutes, laboratories, cell culture collection repositories, contract research organizations (CROS) and pharmaceutical & biotechnology companies and other end users.

The major market players of the global Cell and tissue technology market are:

• AGILENT TECHNOLOGIES, INC.
• BECTON, DICKINSON AND COMPANY
• BIO-RAD LABORATORIES
• DANAHER CORPORATION
• FLUIDIGM CORPORATION
• OTHERS

Detailed analysis of these companies provided in this report comprises Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis.

These companies using various strategies such as merger & acquisition, collaboration, partnership and product launching. For example  in November 2015, Agilent Technologies announced the completion of acquisition of Seahorse Bioscience, a leader in providing instruments and assay kits for measuring bioenergetics and cell metabolism. Similarly, in august 2015, Danaher Corporation announced the completion of the acquisition of Pall Corporation, a New York based company, and a global supplier of filtration, separations and purification products.

Why to buy the report:

This report will:

• Provide you the business strategies adopted by market player such as Danahar Corporation acquired the Pall Corporation of Ney York.
• Provide in detail the different segments such as by consumables, instruments, process and end-users which are affecting the global cell and tissue technology market.
• Provide you the patent analysis of the global cell and tissue technology   market.
• Identify, understand, and the strength, opportunities, challenges and threat of the cell and tissue technology security market.
• Provide revenues of major players of the market such as GE Healthcare, Merck KGAA, Nano string Technologies, Inc., Olympus Corporation.
• Provide you various the regulatory policies which are affecting the global market.

How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global Cell and tissue technology market offers the longest chain of market segmentation covering major market segmentation based on consumables, instrument, process and end-user. The report tracks the major market trends in the global Cell and tissue technology market such as growing importance of cell culture technologies in the research an d development field and the large variety of therapeutics and bimolecular elements. .  For each market segments covered in global cell and tissue technology market report, we provide opportunity matrix, and DRO analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the smart security industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data. 

Key Findings of the global cell and tissue technology market:

• Increasing cases of cancer in the world is fueling the growth in global cell and tissue technology  market.
• North America is anticipated to account the largest revenue share in 2016.
• Increasing government support
• Acquisition is the key strategy adopted by the various market players of global cell and tissue technology market.
• Biotechnology companies, cell structure laboratories and pharmaceutical companies are the major segment of end-user. 

Request for Sample